Gossamer Bio Inc. (GOSS)
1.22
0.03 (2.52%)
At close: Feb 28, 2025, 3:59 PM
1.30
6.56%
Pre-market: Mar 03, 2025, 04:02 AM EST
Gossamer Bio Income Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.38M | 4.43M | 5.17M | 4.27M | 3.09M | 297K | n/a | n/a |
Gross Profit | -4.38M | -4.43M | -5.17M | -4.27M | -3.09M | -297K | n/a | n/a |
Operating Income | -183.76M | -218.59M | -216.12M | -233.96M | -186.14M | -148.99M | -6.65M | -83K |
Interest Income | 2M | 1.58M | 761K | 3.44M | 3.63K | 1.72M | n/a | n/a |
Pretax Income | -179.82M | -229.38M | -234M | -243.36M | -180.31M | -146.97M | -6.77M | -83K |
Net Income | -179.82M | -240.23M | -249.08M | -251.58M | -180.82M | -146.97M | -6.77M | -83K |
Selling & General & Admin | 38.45M | 47.61M | 45.78M | 49.73M | 39.14M | 44.05M | 262K | 83K |
Research & Development | 145.3M | 170.92M | 170.27M | 160.85M | 143.4M | 55.28M | 891K | n/a |
Other Expenses | n/a | 1.51M | 799K | -174K | 5.83M | 316K | n/a | n/a |
Operating Expenses | 183.76M | 218.53M | 216.05M | 210.58M | 182.54M | 99.33M | 1.15M | 83K |
Interest Expense | 13.51M | 13.88M | 19.44M | 12.67M | n/a | 12K | 118K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 183.76M | 218.53M | 216.05M | 210.58M | 182.54M | 99.33M | 1.15M | 83K |
Income Tax | n/a | 10.85M | 15.07M | 8.22M | 511K | 2.04M | -5.38M | -83K |
Shares Outstanding (Basic) | 152.62M | 84.57M | 74.84M | 68.51M | 54.74M | 60.4M | 24.83M | 24.83M |
Shares Outstanding (Diluted) | 152.62M | 84.57M | 74.84M | 68.51M | 54.74M | 60.4M | 24.83M | 24.83M |
EPS (Basic) | -1.18 | -2.84 | -3.33 | -3.67 | -3.3 | -2.43 | -0.27 | -0.00 |
EPS (Diluted) | -1.18 | -2.84 | -3.33 | -3.67 | -3.3 | -2.43 | -0.27 | -0.00 |
EBITDA | -172.15M | -211.07M | -209.32M | -233.96M | -186.14M | -148.99M | -6.65M | -83K |
Depreciation & Amortization | 1.61M | 4.43M | 5.17M | 4.27M | 3.09M | 297K | 1.15M | 83K |